Sputnik V

‘Moderna, AstraZeneca, Pfizer retained activity against new variant but antibody response greatly reduced’

Russian president says he spent an entire day with an infected aide but had not contracted coronavirus

Demand in Russia for tours allowing people to receive foreign vaccines approved by WHO has risen

Country's 35% of the adult population has received the first shot of vaccine, says Asad Umar

Measures include bans on public events with more than 1,000 people, amongst others

Qureshi tells Lavrov two countries should continue to capitalise on shared cooperation

Developer says could produce six times more than previously planned 10 million doses a year

India has so far used two vaccines, one developed by AstraZeneca and Oxford University

Here are some of the country's most notable scientific and technological achievements

Ready to help our Pakistani colleagues meet their needs, says Russian FM during two-day visit to Islamabad

Private sector imports vaccine amid sharp increase in coronavirus cases

Putin had ordered a review by March 15 of Russian-produced vaccines for their effectiveness against new variants

Chughtai Lab director says they will receive 'several thousand doses within the next week'

‘Three months permit’ will be given to the Russian pharmaceutical company

Sputnik V is the third vaccine which is over 90% effective in Phase III trial

Russia launched a voluntary vaccination programme with the Russia-made Sputnik V vaccine earlier in December

Country will be able to count on ‘sufficient doses to be able to vaccinate 10 million Argentines..’

Scientists raise concerns about launching mass vaccinations before full trials to test its safety and efficacy